Real-world frequency of non-small cell lung cancer with ERBB2 exon 20 insertion (Exon20ins) mutations by site of insertion.

被引：0
|
作者：
Yang, Li
Huang, Tanxiao
Qu, Yuan
Wang, Qichen
Teng, Jiaman
Yang, Bo
Chen, Shifu
Kong, Feng-Ming Spring
机构：
[1] Univ Hong Kong, Shenzhen Hosp, Dept Clin Oncol, Shenzhen, Peoples R China
[2] HaploX Biotechnol, Shenzhen, Peoples R China
[3] Univ Hong Kong, Shenzhen Hosp, Shenzhen, Peoples R China
[4] Univ Hong Kong, LKS Fac Med, Dept Clin Oncol, Hong Kong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15026
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real-world frequency of non-small cell lung cancer with epidermal growth factor receptor (EGFR) exon 20 insertion (Exon20ins) mutations by site of insertion
    Viteri, S.
    Bauml, J. M.
    Bazhenova, L.
    Ou, S-H. I.
    Girard, N.
    Schaffer, M.
    Rose, J.
    Curtin, J.
    Karkera, J.
    Mahadevia, P.
    Minchom, A. R.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S699 - S699
  • [2] EGFR exon 20 insertion mutations in non-small cell lung cancer
    Wang, Fenfang
    Li, Chenghui
    Wu, Qihuan
    Lu, Hongyang
    [J]. TRANSLATIONAL CANCER RESEARCH, 2020, 9 (04) : 2982 - 2991
  • [3] Immunotherapy for non-small cell lung cancer with EGFR or HER2 exon 20 insertion mutations: a real-world analysis
    Zhang, Mai
    Huang, Qian
    Yu, Min
    Xue, Jianxin
    Huang, Meijuan
    Lu, You
    Zhang, Yan
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (04) : 797 - 807
  • [4] Real-World Treatment Patterns and Survival in Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations
    Dersarkissian, M.
    Bhak, R.
    Lin, H.
    Li, S.
    Cheng, M.
    Lax, A.
    Huang, H.
    Duh, M.
    Ou, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S681 - S681
  • [5] Real-world clinical treatment outcomes in Chinese non-small cell lung cancer with EGFR exon 20 insertion mutations
    Shi, Chao
    Xing, Ruyue
    Li, Mengmeng
    Feng, Junnan
    Sun, Rui
    Wei, Bing
    Guo, Yongjun
    Ma, Jie
    Wang, Huijuan
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] Real-world outcomes in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations receiving mobocertinib
    Mok, T. S. K.
    Liu, G.
    Nyaw, S. F.
    Curcio, H.
    Cortot, A.
    Kam, T. Y.
    Descourt, R.
    Chik, Y. K.
    Cheema, P. K.
    Gwinnutt, J. M.
    Churchill, E. N.
    Nyborn, J.
    Curran, E.
    Yin, Y.
    Chong, K.
    Tanaka-Chambers, Y.
    Kretz, J.
    Cadranel, J.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1698 - S1699
  • [7] Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
    Vyse, Simon
    Huang, Paul H.
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2019, 4 (1)
  • [8] Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
    Simon Vyse
    Paul H. Huang
    [J]. Signal Transduction and Targeted Therapy, 4
  • [9] A real-world study of the efficacy and safety of furmonertinib for patients with non-small cell lung cancer with EGFR exon 20 insertion mutations
    Huanlan Sa
    Yan Shi
    Chunxia Ding
    Kewei Ma
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 7729 - 7742
  • [10] A real-world study of the efficacy and safety of furmonertinib for patients with non-small cell lung cancer with EGFR exon 20 insertion mutations
    Sa, Huanlan
    Shi, Yan
    Ding, Chunxia
    Ma, Kewei
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (10) : 7729 - 7742
12345